Museveni commissions starch-manufacturing plant in Kamuli
“From his early work in Matugga (Wakiso district) on malaria remedies rooted in our ancient knowledge, to the vibrant progress we see today, he continues to make a real contribution to Uganda’s wealth creation journey,” Museveni noted.
Museveni has commissioned new projects of scientist and founder of Dei BioPharma Ltd, Dr Matthias Magoola, in Busambo village, Namasagali sub-county in Kamuli district.
KAMULI - President Yoweri Museveni has commissioned new projects of scientist and founder of Dei BioPharma Ltd, Dr Matthias Magoola, in Busambo village, Namasagali sub-county in Kamuli district.
This was on Thursday, November 20, 2025, before he addressed his second and final 2026 re-election campaign rally at Bupadhengo Primary School playgrounds in Kamuli.
He was accompanied by First Lady and Minister of Education and Sports Janet Kataha Museveni, in commissioning the Dei Group Advanced Agro-Processing Park and a new starch manufacturing plant.
Museveni congratulated Dr. Magoola for his innovation and resilience, according to a statement shared by his press unit.
“From his early work in Matugga (Wakiso district) on malaria remedies rooted in our ancient knowledge, to the vibrant progress we see today, he continues to make a real contribution to Uganda’s wealth creation journey,” he noted.
Magoola’s Matugga firm specialises in the development and manufacturing of innovative medicines and vaccines.
The President was accompanied by First Lady and Minister of Education and Sports Janet Kataha Museveni, in commissioning the Dei Group Advanced Agro-Processing Park and a new starch manufacturing plant.
The scientist, who is currently developing a multi-billion-dollar drugs and vaccines manufacturing plant in Matugga, says he has more than 100 patents filed in the US for treating different diseases and vaccines, including cancer, HIV, Alzheimer's, Malaria, TB, Diabetes, among others.
One of his patents encodes darbepoetin, a therapeutic protein used for the treatment of acute kidney failure and cancer using mRNA, is the first such product in the world that has already been submitted to the US Food and Drug Administration (FDA) for approval review.
The FDA has reportedly taken great interest in advising Magoola on how to bring this product to patients worldwide.
Museveni also thanked Ugandan government partners, including those from the United States, who are supporting these efforts of Ugandan scientists.
He also used the occasion to congratulate the People’s Republic of China on their long-standing cooperation with Africa since 1949.
“Together, we have today flagged off the first container of Ugandan chilli for export to China, another milestone in our march to prosperity,” Museveni added.